Literature DB >> 4154793

Blood and neoplastic diseases. Acute myeloblastic leukaemia.

M L Willoughby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4154793      PMCID: PMC1612881          DOI: 10.1136/bmj.4.5940.337

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria.

Authors:  R G Graw; G Herzig; S Perry; E S Henderson
Journal:  N Engl J Med       Date:  1972-08-24       Impact factor: 91.245

2.  Initial therapy with combination of five antibiotics in febrile patients with leukaemia and neutropenia.

Authors:  M H Tattersall; A S Spiers; J H Darrell
Journal:  Lancet       Date:  1972-01-22       Impact factor: 79.321

3.  The treatment of acute granulocytic leukemia in adults.

Authors:  D S Rosenthal; W C Moloney
Journal:  N Engl J Med       Date:  1972-06-01       Impact factor: 91.245

4.  Acute myelocytic leukemia in adults.

Authors:  B D Clarkson
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

5.  Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.

Authors:  W Paolino; L Resegotti; M Rossi; V Infelise
Journal:  Br Med J       Date:  1973-09-15

6.  Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults.

Authors:  J P Whitecar; G P Bodey; E J Freireich; K B McCredie; J S Hart
Journal:  Cancer Chemother Rep       Date:  1972-08

7.  Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia.

Authors:  E M Hersh; J P Whitecar; K B McCredie; G P Bodey; E J Freireich
Journal:  N Engl J Med       Date:  1971-11       Impact factor: 91.245

8.  Treatment of adult acute leukemia with arabinosylcytosine and thioguanine.

Authors:  T S Gee; K P Yu; B D Clarkson
Journal:  Cancer       Date:  1969-05       Impact factor: 6.860

9.  Immunotherapy for acute myelogenous leukaemia.

Authors:  R L Powles; D Crowther; C J Bateman; M E Beard; T J McElwain; J Russell; T A Lister; J M Whitehouse; P F Wrigley; M Pike; P Alexander; G H Fairley
Journal:  Br J Cancer       Date:  1973-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.